Joanne Wuensch
Stock Analyst at Citigroup
(4.39)
# 335
Out of 5,090 analysts
426
Total ratings
64.91%
Success rate
12.05%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITGR Integer Holdings | Maintains: Neutral | $77 → $69 | $69.84 | -1.20% | 8 | Nov 3, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $12 → $11 | $13.23 | -16.86% | 16 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $26 → $21 | $18.54 | +13.27% | 22 | Oct 31, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $205 → $242 | $178.37 | +35.67% | 22 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $95 → $96 | $86.19 | +11.38% | 21 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $85 → $75 | $65.49 | +14.52% | 16 | Oct 31, 2025 | |
| GKOS Glaukos | Maintains: Buy | $110 → $113 | $108.51 | +4.14% | 22 | Oct 30, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $213 → $215 | $201.93 | +6.47% | 15 | Oct 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $11 → $15 | $20.92 | -28.30% | 20 | Oct 7, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4.5 → $4 | $8.05 | -50.31% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $101.36 | +10.50% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $64 | $83.94 | -23.76% | 9 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $83 | $85.46 | -2.88% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $97 → $72 | $81.40 | -11.55% | 21 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $157 → $155 | $125.08 | +23.92% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $320 → $285 | $300.66 | -5.21% | 25 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $47 | $70.79 | -33.61% | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $16.82 | -10.82% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $443 → $455 | $364.02 | +24.99% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $2.01 | +106.47% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $575.34 | +12.98% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $304.49 | +24.80% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $97.52 | +28.18% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $94.28 | +27.28% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $193.96 | +28.89% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $80.73 | -14.53% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $256.55 | -50.50% | 6 | Dec 10, 2018 |
Integer Holdings
Nov 3, 2025
Maintains: Neutral
Price Target: $77 → $69
Current: $69.84
Upside: -1.20%
Integra LifeSciences Holdings
Oct 31, 2025
Maintains: Sell
Price Target: $12 → $11
Current: $13.23
Upside: -16.86%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $26 → $21
Current: $18.54
Upside: +13.27%
iRhythm Technologies
Oct 31, 2025
Maintains: Buy
Price Target: $205 → $242
Current: $178.37
Upside: +35.67%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $95 → $96
Current: $86.19
Upside: +11.38%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $85 → $75
Current: $65.49
Upside: +14.52%
Glaukos
Oct 30, 2025
Maintains: Buy
Price Target: $110 → $113
Current: $108.51
Upside: +4.14%
Johnson & Johnson
Oct 15, 2025
Maintains: Buy
Price Target: $213 → $215
Current: $201.93
Upside: +6.47%
Tandem Diabetes Care
Oct 7, 2025
Maintains: Neutral
Price Target: $11 → $15
Current: $20.92
Upside: -28.30%
Sight Sciences
Oct 7, 2025
Maintains: Neutral
Price Target: $4.5 → $4
Current: $8.05
Upside: -50.31%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $101.36
Upside: +10.50%
Oct 7, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $83.94
Upside: -23.76%
Oct 7, 2025
Downgrades: Neutral
Price Target: $93 → $83
Current: $85.46
Upside: -2.88%
Aug 28, 2025
Downgrades: Neutral
Price Target: $97 → $72
Current: $81.40
Upside: -11.55%
Jul 18, 2025
Maintains: Buy
Price Target: $157 → $155
Current: $125.08
Upside: +23.92%
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $300.66
Upside: -5.21%
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $70.79
Upside: -33.61%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $16.82
Upside: -10.82%
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $364.02
Upside: +24.99%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $2.01
Upside: +106.47%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $575.34
Upside: +12.98%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $304.49
Upside: +24.80%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $97.52
Upside: +28.18%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $94.28
Upside: +27.28%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $193.96
Upside: +28.89%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $80.73
Upside: -14.53%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $256.55
Upside: -50.50%